BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38072373)

  • 1. Rehabilitation facilitates functional improvement following intravenous infusion of mesenchymal stem cells in the chronic phase of cerebral ischemia in rats.
    Yamashita T; Sasaki M; Sasaki Y; Nagahama H; Oka S; Kataoka-Sasaki Y; Ukai R; Yokoyama T; Kobayashi M; Kakizawa M; Kocsis JD; Honmou O
    Brain Res; 2024 Feb; 1825():148709. PubMed ID: 38072373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergic Effects of Rehabilitation and Intravenous Infusion of Mesenchymal Stem Cells After Stroke in Rats.
    Sasaki Y; Sasaki M; Kataoka-Sasaki Y; Nakazaki M; Nagahama H; Suzuki J; Tateyama D; Oka S; Namioka T; Namioka A; Onodera R; Mikami T; Wanibuchi M; Kakizawa M; Ishiai S; Kocsis JD; Honmou O
    Phys Ther; 2016 Nov; 96(11):1791-1798. PubMed ID: 27174259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats.
    Nakazaki M; Sasaki M; Kataoka-Sasaki Y; Oka S; Namioka T; Namioka A; Onodera R; Suzuki J; Sasaki Y; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
    J Neurosurg; 2017 Oct; 127(4):917-926. PubMed ID: 28059661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous Infusion of Mesenchymal Stem Cells Enhances Therapeutic Efficacy of Reperfusion Therapy in Cerebral Ischemia.
    Kiyose R; Sasaki M; Kataoka-Sasaki Y; Nakazaki M; Nagahama H; Magota H; Oka S; Ukai R; Takemura M; Yokoyama T; Kocsis JD; Honmou O
    World Neurosurg; 2021 May; 149():e160-e169. PubMed ID: 33618048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated brain derived neurotrophic factor levels in plasma reflect in vivo functional viability of infused mesenchymal stem cells for stroke in rats.
    Nakamura H; Sasaki Y; Sasaki M; Kataoka-Sasaki Y; Oka S; Nakazaki M; Namioka T; Namioka A; Onodera R; Suzuki J; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
    J Neurosurg Sci; 2019 Feb; 63(1):42-49. PubMed ID: 28181779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated intravenous infusion of mesenchymal stem cells for enhanced functional recovery in a rat model of chronic cerebral ischemia.
    Takemura M; Sasaki M; Kataoka-Sasaki Y; Kiyose R; Nagahama H; Oka S; Ukai R; Yokoyama T; Kocsis JD; Ueba T; Honmou O
    J Neurosurg; 2022 Aug; 137(2):402-411. PubMed ID: 34861644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of interhemispheric cortical connections through corpus callosum following intravenous infusion of mesenchymal stem cells in a rat model of cerebral infarction.
    Nagahama H; Nakazaki M; Sasaki M; Kataoka-Sasaki Y; Namioka T; Namioka A; Oka S; Onodera R; Suzuki J; Sasaki Y; Kocsis JD; Honmou O
    Brain Res; 2018 Sep; 1695():37-44. PubMed ID: 29802840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia.
    Komatsu K; Honmou O; Suzuki J; Houkin K; Hamada H; Kocsis JD
    Brain Res; 2010 Jun; 1334():84-92. PubMed ID: 20382136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model.
    Suzuki J; Sasaki M; Harada K; Bando M; Kataoka Y; Onodera R; Mikami T; Wanibuchi M; Mikuni N; Kocsis JD; Honmou O
    Brain Res; 2013 Feb; 1497():15-22. PubMed ID: 23274536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated intravenous infusion of mesenchymal stem cells enhances recovery of motor function in a rat model with chronic spinal cord injury.
    Kurihara K; Sasaki M; Nagahama H; Obara H; Fukushi R; Hirota R; Yoshimoto M; Teramoto A; Kocsis JD; Yamashita T; Honmou O
    Brain Res; 2023 Oct; 1817():148484. PubMed ID: 37442249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.
    Honma T; Honmou O; Iihoshi S; Harada K; Houkin K; Hamada H; Kocsis JD
    Exp Neurol; 2006 May; 199(1):56-66. PubMed ID: 15967439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model.
    Wakabayashi K; Nagai A; Sheikh AM; Shiota Y; Narantuya D; Watanabe T; Masuda J; Kobayashi S; Kim SU; Yamaguchi S
    J Neurosci Res; 2010 Apr; 88(5):1017-25. PubMed ID: 19885863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells with modafinil (gold nanoparticles) significantly improves neurological deficits in rats after middle cerebral artery occlusion.
    Nazarian S; Abdolmaleki Z; Torfeh A; Shirazi Beheshtiha SH
    Exp Brain Res; 2020 Nov; 238(11):2589-2601. PubMed ID: 32886135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of IL-10 and TNF-alpha in rats with cerebral infarction after transplantation with mesenchymal stem cells.
    Liu N; Chen R; Du H; Wang J; Zhang Y; Wen J
    Cell Mol Immunol; 2009 Jun; 6(3):207-13. PubMed ID: 19567204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treadmill exercise enhances therapeutic potency of transplanted bone mesenchymal stem cells in cerebral ischemic rats via anti-apoptotic effects.
    Zhang YX; Yuan MZ; Cheng L; Lin LZ; Du HW; Chen RH; Liu N
    BMC Neurosci; 2015 Sep; 16():56. PubMed ID: 26342636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection by mesenchymal stem cell (MSC) administration is enhanced by local cooling infusion (LCI) in ischemia.
    Wei W; Wu D; Duan Y; Elkin KB; Chandra A; Guan L; Peng C; He X; Wu C; Ji X; Ding Y
    Brain Res; 2019 Dec; 1724():146406. PubMed ID: 31454517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats.
    Omori Y; Honmou O; Harada K; Suzuki J; Houkin K; Kocsis JD
    Brain Res; 2008 Oct; 1236():30-8. PubMed ID: 18722359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia.
    Liu H; Honmou O; Harada K; Nakamura K; Houkin K; Hamada H; Kocsis JD
    Brain; 2006 Oct; 129(Pt 10):2734-45. PubMed ID: 16901914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous infusion of mesenchymal stem cells promotes functional recovery in a rat model of chronic cerebral infarction.
    Namioka T; Namioka A; Sasaki M; Kataoka-Sasaki Y; Oka S; Nakazaki M; Onodera R; Suzuki J; Sasaki Y; Nagahama H; Kocsis JD; Honmou O
    J Neurosurg; 2018 Oct; 131(4):1289-1296. PubMed ID: 30485210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.
    Nomura T; Honmou O; Harada K; Houkin K; Hamada H; Kocsis JD
    Neuroscience; 2005; 136(1):161-9. PubMed ID: 16229956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.